Total Payments
$35,967
2021 Payments
$653.31
Companies
41
Transactions
451
Medicare Patients
6,265
Medicare Billing
$2.1M
Payment Breakdown by Category
Other$14,225 (39.6%)
Consulting$11,160 (31.0%)
Food & Beverage$6,660 (18.5%)
Travel$3,652 (10.2%)
Education$270.43 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,225 | 8 | 39.6% |
| Consulting Fee | $11,160 | 4 | 31.0% |
| Food and Beverage | $6,660 | 425 | 18.5% |
| Travel and Lodging | $3,652 | 10 | 10.2% |
| Education | $270.43 | 4 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $22,157 | 83 | $0 (2021) |
| Janssen Biotech, Inc. | $5,845 | 79 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $3,360 | 1 | $0 (2020) |
| AbbVie Inc. | $586.44 | 36 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $455.14 | 24 | $0 (2021) |
| LEO Pharma Inc. | $375.18 | 34 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $334.89 | 15 | $0 (2021) |
| Galderma Laboratories, L.P. | $326.25 | 18 | $0 (2021) |
| Lilly USA, LLC | $288.27 | 19 | $0 (2021) |
| Celgene Corporation | $287.63 | 28 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $653.31 | 39 | AbbVie Inc. ($192.89) |
| 2020 | $5,053 | 51 | E.R. Squibb & Sons, L.L.C. ($3,360) |
| 2019 | $6,575 | 95 | PFIZER INC. ($5,304) |
| 2018 | $21,971 | 147 | PFIZER INC. ($15,778) |
| 2017 | $1,715 | 119 | Janssen Biotech, Inc. ($194.18) |
All Payment Transactions
451 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/12/2021 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Immunology | ||||||
| 08/26/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: IMMUNOLOGY | ||||||
| 08/18/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $5.17 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.38 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/12/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Inflammation | ||||||
| 08/10/2021 | Almirall LLC | Seysara (Drug) | Food and Beverage | Cash or cash equivalent | $13.67 | General |
| Category: Dermatology | ||||||
| 08/03/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $18.34 | General |
| 07/22/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Inflammation | ||||||
| 07/14/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: IMMUNOLOGY | ||||||
| 07/01/2021 | Almirall LLC | Seysara (Drug) | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| Category: Dermatology | ||||||
| 06/30/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: IMMUNOLOGY | ||||||
| 06/23/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2021 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Inflammation | ||||||
| 06/17/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/15/2021 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: DERMATOLOGY | ||||||
| 06/01/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: DERMATOLOGY | ||||||
| 05/18/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Ilumya (Biological) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Dermatology | ||||||
| 05/18/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $7.71 | General |
| 05/14/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: IMMUNOLOGY | ||||||
| 05/04/2021 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: IMMUNOLOGY | ||||||
| 04/22/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: IMMUNOLOGY | ||||||
| 04/14/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Ilumya (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 33 | 2,100 | 6,894 | $3.2M | $785,224 |
| 2020 | 43 | 4,165 | 12,307 | $6.0M | $1.3M |
Total Patients
6,265
Total Services
19,201
Medicare Billing
$2.1M
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Management of radiation therapy simulation, simple | Office | 2021 | 76 | 1,461 | $1.2M | $310,823 | 26.8% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2021 | 79 | 1,455 | $351,819 | $167,006 | 47.5% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2021 | 107 | 130 | $380,810 | $64,211 | 16.9% |
| 77401 | Radiation treatment delivery, superficial | Office | 2021 | 76 | 1,404 | $147,055 | $44,764 | 30.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 426 | 737 | $138,939 | $42,908 | 30.9% |
| 17313 | Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks) | Office | 2021 | 45 | 49 | $131,898 | $23,142 | 17.5% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2021 | 49 | 70 | $124,695 | $21,849 | 17.5% |
| 13121 | Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | Office | 2021 | 56 | 63 | $103,926 | $13,201 | 12.7% |
| 13132 | Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2021 | 61 | 68 | $165,823 | $13,016 | 7.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 133 | 169 | $46,171 | $13,001 | 28.2% |
| 13101 | Repair of wound (2.6 to 7.5 centimeters) of trunk | Office | 2021 | 27 | 31 | $37,242 | $7,480 | 20.1% |
| 11311 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 66 | 73 | $27,296 | $6,095 | 22.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 151 | 170 | $51,617 | $5,991 | 11.6% |
| 11310 | Shaving of 0.5 centimeters or less skin growth of face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 77 | 86 | $27,367 | $5,763 | 21.1% |
| 17314 | Removal and microscopic examination of growth of the trunk, arms, or legs (additional stage, up to 5 tissue blocks) | Office | 2021 | 12 | 15 | $24,939 | $4,478 | 18.0% |
| 11301 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs | Office | 2021 | 57 | 57 | $18,139 | $4,223 | 23.3% |
| 13131 | Repair of wound (1.1 to 2.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2021 | 24 | 24 | $29,681 | $4,214 | 14.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 76 | 76 | $22,118 | $3,910 | 17.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $12,659 | $3,472 | 27.4% |
| 77300 | Calculation of radiation therapy dose | Office | 2021 | 66 | 67 | $12,595 | $3,341 | 26.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 46 | 50 | $17,079 | $3,335 | 19.5% |
| 11302 | Shaving of 1.1 to 2.0 centimeters skin growth of the trunk, arms, or legs | Office | 2021 | 39 | 43 | $16,249 | $2,925 | 18.0% |
| 11306 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of scalp, neck, hands, feet, or genitals | Office | 2021 | 35 | 37 | $12,510 | $2,509 | 20.1% |
| 11305 | Shaving of 0.5 centimeters or less skin growth of scalp, neck, hands, feet, or genitals | Office | 2021 | 40 | 41 | $11,416 | $2,414 | 21.1% |
| 11312 | Shaving of 1.1 to 2.0 centimeters skin growth of face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 20 | 22 | $9,626 | $2,332 | 24.2% |
About Dr. Ashvin Garlapati, D.O
Dr. Ashvin Garlapati, D.O is a MOHS-Micrographic Surgery healthcare provider based in Crown Point, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1417246851.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashvin Garlapati, D.O has received a total of $35,967 in payments from pharmaceutical and medical device companies, with $653.31 received in 2021. These payments were reported across 451 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,225).
As a Medicare-enrolled provider, Garlapati has provided services to 6,265 Medicare beneficiaries, totaling 19,201 services with total Medicare billing of $2.1M. Data is available for 2 years (2020–2021), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Crown Point, IN
- Active Since 04/06/2011
- Last Updated 02/17/2021
- Taxonomy Code 207ND0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417246851
Products in Payments
- EUCRISA (Drug) $20,759
- Tremfya (Drug) $5,368
- COSENTYX (Biological) $455.14
- ENSTILAR (Drug) $300.65
- TALTZ (Drug) $288.27
- Humira (Biological) $196.58
- SKYRIZI (Biological) $192.89
- EPIDUO FORTE (Drug) $186.09
- TREMFYA (Drug) $184.00
- DUPIXENT (Biological) $183.45
- HUMIRA (Biological) $170.92
- REMICADE (Biological) $167.85
- Finacea (Drug) $151.00
- DORYX (Drug) $144.33
- DUPIXENT DUPILUMAB INJECTION (Biological) $134.99
- DUPIXENT (Drug) $133.64
- XALKORI (Drug) $131.68
- Otezla (Drug) $126.80
- STELARA (Biological) $125.16
- Enbrel (Biological) $122.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.